166 related articles for article (PubMed ID: 11231342)
1. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
Garber SL; Mirochnik Y; Brecklin CS; Unemori EN; Singh AK; Slobodskoy L; Grove BH; Arruda JA; Dunea G
Kidney Int; 2001 Mar; 59(3):876-82. PubMed ID: 11231342
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis.
Garber SL; Mirochnik Y; Desai SS; Arruda JA; Dunea G
J Am Soc Nephrol; 1998 Jun; 9(6):1052-9. PubMed ID: 9621288
[TBL] [Abstract][Full Text] [Related]
3. Changes in collagenases and TGF-beta precede structural alterations in a model of chronic renal fibrosis.
Mo W; Brecklin C; Garber SL; Song RH; Pegoraro AA; Au J; Arruda JA; Dunea G; Singh AK
Kidney Int; 1999 Jul; 56(1):145-53. PubMed ID: 10411687
[TBL] [Abstract][Full Text] [Related]
4. Evolution of experimentally induced papillary necrosis to focal segmental glomerulosclerosis and nephrotic proteinuria.
Garber SL; Mirochnik Y; Arruda JA; Dunea G
Am J Kidney Dis; 1999 Jun; 33(6):1033-9. PubMed ID: 10352190
[TBL] [Abstract][Full Text] [Related]
5. Relaxin and the progression of kidney disease.
Samuel CS; Hewitson TD
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):9-14. PubMed ID: 19077683
[TBL] [Abstract][Full Text] [Related]
6. Relaxin in cardiovascular and renal disease.
Samuel CS; Hewitson TD
Kidney Int; 2006 May; 69(9):1498-502. PubMed ID: 16672919
[TBL] [Abstract][Full Text] [Related]
7. Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis.
Samuel CS; Mookerjee I; Masterson R; Tregear GW; Hewitson TD
Ann N Y Acad Sci; 2005 May; 1041():182-4. PubMed ID: 15956704
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis.
Hewitson TD; Ho WY; Samuel CS
Endocrinology; 2010 Oct; 151(10):4938-48. PubMed ID: 20826562
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.
Morrissey J; Hruska K; Guo G; Wang S; Chen Q; Klahr S
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S14-21. PubMed ID: 11792757
[TBL] [Abstract][Full Text] [Related]
10. Effect of relaxin in two models of renal mass reduction.
Garber SL; Mirochnik Y; Brecklin C; Slobodskoy L; Arruda JA; Dunea G
Am J Nephrol; 2003; 23(1):8-12. PubMed ID: 12373075
[TBL] [Abstract][Full Text] [Related]
11. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
12. Effect of bromoethylamine hydrobromide on systemic acid-base balance.
Nakamura Y; Sasaki S; Shigai T; Marumo F
Tohoku J Exp Med; 1988 Sep; 156(1):23-32. PubMed ID: 3194903
[TBL] [Abstract][Full Text] [Related]
13. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
[TBL] [Abstract][Full Text] [Related]
14. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
Ma LJ; Nakamura S; Whitsitt JS; Marcantoni C; Davidson JM; Fogo AB
Kidney Int; 2000 Dec; 58(6):2425-36. PubMed ID: 11115076
[TBL] [Abstract][Full Text] [Related]
15. Relaxin: an endogenous renoprotective factor?
Hewitson TD; Samuel CS
Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat.
Chen CO; Park MH; Forbes MS; Thornhill BA; Kiley SC; Yoo KH; Chevalier RL
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F946-55. PubMed ID: 17107943
[TBL] [Abstract][Full Text] [Related]
17. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta.
Wright EJ; McCaffrey TA; Robertson AP; Vaughan ED; Felsen D
Lab Invest; 1996 Feb; 74(2):528-37. PubMed ID: 8780170
[TBL] [Abstract][Full Text] [Related]
18. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis.
Samuel CS; Zhao C; Bond CP; Hewitson TD; Amento EP; Summers RJ
Kidney Int; 2004 Jun; 65(6):2054-64. PubMed ID: 15149318
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance microscopy of toxic renal injury induced by bromoethylamine in rats.
Hedlund LW; Maronpot RR; Johnson GA; Cofer GP; Mills GI; Wheeler CT
Fundam Appl Toxicol; 1991 May; 16(4):787-97. PubMed ID: 1884916
[TBL] [Abstract][Full Text] [Related]
20. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
Negri AL
J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
